Advertisement

Mammakarzinom und Umweltfaktoren

Part of the Onkologie Aktuell book series (ONKAKTUELL)

Zusammenfassung

In westlichen Industrieländern ist das Mammakarzinom der häufigste bösartige Tumor der Frau. So waren im Jahre 1997 ca.26% aller Krebsneuerkrankungen bei Frauen Malignome der Brustdrüse (ICD-Code 174), 18% aller weiblichen Krebstoten verstarben an einem Mammakarzinom (Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland, 1999).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ambrosone CB, Freudenheim JL, Graham S et al. (1995) Cytochrome P450 lAi and glutathione S-transferase (Mi) genetic polymorphisms and postmenopausal breast cancer risk. Cancer-Res 55(16): 3483–3485PubMedGoogle Scholar
  2. Ambrosone CB, Freudenheim JL, Graham S et al. (1996) Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA 276(18): 1494–1501PubMedCrossRefGoogle Scholar
  3. Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland (1999) Krebs in Deutschland, Häufigkeiten und Trends.2. aktualisierte AusgabeGoogle Scholar
  4. Bartsch C, Bartsch H., Jain AK, Laaumas KR, Wetterberg L (1981) Uninary melatonin levels in human breast cancer patients. J Neural Transm 52: 269–279PubMedCrossRefGoogle Scholar
  5. Bennicke K, Conrad C, Sabroe S, Sorensen HT (1995) Cigarette smoking and breast cancer. BMJ 310(6992): 1431–1433PubMedCrossRefGoogle Scholar
  6. Bernhardt JH (1999) In: Mersch-Sundermann V: Umweltmedizin — Grundlagen der Umweltmedizin, klinische Umweltmedizin, ökologische Medizin. Stuttgart, New York: Thieme: 118–126Google Scholar
  7. Bertazzi PA, Pesatori AC, Landi MT (1996) Cancer mortality, 1976–1991, in the population exposed to 2,3,7,8-Tetrachloro-dibenzo-p-dioxin. Organohalogen Compounds 30: 294–297Google Scholar
  8. Bradlow HL, Michnovicz JJ, Telang NT, Osborne MP (1991) Diet, oncogenes and tumor viruses as modulators of estrogen metabolism in vivo and in vitro. Cancer Prev Dect S16: 35–42Google Scholar
  9. Bradlow HL, Sepkovic DW, Telang NT, Osborne MP (1995) índoles-carbinol. A novel approach to breast cancer prevention. Ann N Y Acad Sci 768:180–200PubMedCrossRefGoogle Scholar
  10. Bradlow HL, Telang NT, Sepkovic DW, Osborne MP (1996) 2-hydroxyestrone: the ‘good’ estrogen. J Endocrinol 150 Suppl: S259–65Google Scholar
  11. Braga C, Negri E, La Vecchia C, Filiberti R, Franceschi S (1996) Cigarette smoking and the risk of breast cancer. Eur J Cancer Prev 5(3): 159–164PubMedCrossRefGoogle Scholar
  12. Brown NM, Manzolillo PA, Zhang JX, Wang J, Lamartiniere CA (1998) Prenatal TCDD and predisposition to mammary cancer in the rat. Carcinogenesis 19(9): 1623–1629PubMedCrossRefGoogle Scholar
  13. Cantor KP, Dosemeci M., Brinton LA, Stewart PA (1995) Re: Breast cancer mortality among female electrical workers in the United States. J Natl Cancer Inst 87:227–228PubMedCrossRefGoogle Scholar
  14. Caplan LS, Schoenfeld ER, O’Leary E, Leske MC (2000) Breast cancer and electromegnetic fields — a review. AEP 10 (1): 31–44PubMedGoogle Scholar
  15. Coogan PF, Aschengrau A (1998) Exposure to power frequency magnetic fields and the risk of breast cancer among female electrical workers in the upper Cape Cod incidence study. Arch Environ Health 53:359–367PubMedCrossRefGoogle Scholar
  16. Davidson NE (1998) Environmental estrogens and breast cancer risk Current Opinion in Oncology 10: 475–478CrossRefGoogle Scholar
  17. Davis DL, Bradlow HL (1995) Can environmental estrogens cause breast cancer? Scientific American 10/95:144–149Google Scholar
  18. Davis DL, Bradlow HL, Wolff M, Woodruff T, Hoel DG, Anton-Culver H (1993) Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect 101:372–376PubMedCrossRefGoogle Scholar
  19. Demers PA, Thomas DB, Rosenblatt KA et al. (1991) Occupational exposure to electromagnetic fields and breast cancer in men. Am J Epidemiol 134:340–347PubMedGoogle Scholar
  20. Dewailly E, Dodin S, Verreault R, Ayotte P, Sauve L, Morin J (1993) High organochlorine body burden in breast cancer women with estrogen receptors. Organohalogen Compounds 13:385–388Google Scholar
  21. Dunn JF, Nisula B, Rodbard D (1991) Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endo Metab 53:58–64CrossRefGoogle Scholar
  22. Falck F, Ricci A, Wolff MS, Godbold J, Deckers P (1992) Pesticides and polychlorinated biphenyls residues in human breast lipids and their relation to breast cancer. Arch Environ Health 47 (2): 143–146PubMedGoogle Scholar
  23. Fear NT, Roman E, Carpenter LM, Newton R, Bull D (1996) Cancer in eletrical workers: an analysis of cancer registrations in England 1981–87. Br J Cancer 73:935–939PubMedCrossRefGoogle Scholar
  24. Flesch-Janys D, Berger J, Manz A, Nagel S, Ollroge I (1993) Exposure to polychlorinated dibenzo-p-dioxins and -furans and breast cancer mortality in a cohort of female workers of a herbicide producing plant in Hamburg, FRG. Organohalogen Compounds 13:381–384Google Scholar
  25. Gapstur SM, Potter JD, Drinkard C, Folsom AR (1995) Synergistic effect between alcohol and estrogen replacement therapy on risk of breast cancer differs by estrogen/progesterone receptor status in the Iowa Women’s Health Study. Cancer Epidemiol Biomarkers Prev 4(4): 313–318PubMedGoogle Scholar
  26. Ginsburg ES, Walsh BW, Shea BF, Gao X, Gleason RE, Feltmate C, Barbieri RL (1995) Effect of acute ethanol ingestion on prolactin in menopausal women using estradiol replacement. Gynecol Obstet Invest 39(1): 47–49PubMedCrossRefGoogle Scholar
  27. Guenel P, Rasmark P, Andersen JB et al. (1993) Incidence of cancer in persons with occupational exposure to electromagnetic fields in Denmark. Br J Ind Med 50: 758–764PubMedGoogle Scholar
  28. Güttes S, Failing K, Neumann K, Kleinstein J, Georgii, Brunn H (1998) Chlororganic pesticides and polychlorinated biphenyls in breast tissue of women with benign and malignant breast disease. Arch Environ Contam Toxicol 35: 140–147PubMedCrossRefGoogle Scholar
  29. Hanf V, Körner W (1999) Gynäkologie Teil 2: Umweltmedizinische Bedeutung endokriner Disruptoren. In: Beyer A, Eis D: Praktische Umweltmedizin — Klinik, Methoden, Arbeitshilfen. Abschnitt 03.11, Folgelieferung 3/99: 1–28. Heidelberg: SpringerGoogle Scholar
  30. Hoyer AP, Grandjean P, Jorgensen T, Brock JW, Hartvig HB (1998) Organochlorine exposure and risk of breast cancer. Lancet 352:1816–1820PubMedCrossRefGoogle Scholar
  31. Hunter DJ, Hankinson SE, Laden F et al. (1997) Plasma organochlorine levels and the risk of breast cancer. N Engl J Med 337:1253–1258PubMedCrossRefGoogle Scholar
  32. ICRP Publication 60/1990: Recommendations of the International Commission on Radiological Protection. ICRP publication 60, Pergamon Press, Annals of the ICRP 21, No. 1–3Google Scholar
  33. Johansen C, Olsen JH (1998) Risk of cancer among Danish utility workers — a nationwide cohort study. Am J Epidemiol 147: 548–555PubMedCrossRefGoogle Scholar
  34. Katsouyanni K, Trichopoulou A, Stuver S et al. (1994) Ethanol and breast cancer: an association that may be both confounded and causal. Int J Cancer 58(3): 356–361PubMedCrossRefGoogle Scholar
  35. Kelsh MA, Sahl JD (1997) Mortality among a cohort of electric utility workers, 1960–1991. Am J Industr Med 31: 534–544CrossRefGoogle Scholar
  36. Kociba RJ, Keyes DG, Beyer JE et al. (1978) Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlo-rodibenzo-p-dioxin in rats. Toxic Appl Pharmac 46:279–303CrossRefGoogle Scholar
  37. Körner W, Hanf V, Faust A, Temmen R, Tinneberg H-R, Hagenmaier H (1994) Concentrations and profiles of PCDDs and PCDFs in human mammary carcinoma tissue. Chemosphe-re 29(9–11): 2339–2347CrossRefGoogle Scholar
  38. Körner W, Hanf V, Schuller W, Bartsch H, Kreienberg R, Hagen-maier H (1996) Validation and application of a rapid in vitro assay for assessing the estrogenic potency of halogenated phenolic chemicals. Organohalogen Compounds 27:297–302Google Scholar
  39. Krieger N, Wolff MS, Hiatt RA, Rivera M, Vogelman J, Orent-reich N (1994) Breast cancer and serum organochlorides: a prospective study among white, black, and Asian women. J Natl Cancer Inst 86:589–599PubMedCrossRefGoogle Scholar
  40. La Vecchia C, Negri E, Parazzini F, Boyle P, Fasoli M, Gentile A, Franceschi S (1989) Alcohol and breast cancer: update from an Italian case-control study. Eur J Cancer Clin Oncol 25(12): 1711–1717PubMedCrossRefGoogle Scholar
  41. Lamartiniere CA, Moore J, Holland M, Barnes S (1995) Neonatal genistein chemoprevents mammary cancer. Proc Soc Exp Biol Med 208:120–123PubMedGoogle Scholar
  42. Li D, Wang M, Dhingra K, Hittelman W-NTI (1996) Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer-Res 56(2): 287–293PubMedGoogle Scholar
  43. Liburdy RP, Sloma TR, Sokolic R et al. (1993) ELF magnetic fields, breast cancer and melatonin: 60 Hz fields block melatonin’s oncostatic action on ER+ breast cancer cell proliferation. J Pineal Res 14: 89–97PubMedCrossRefGoogle Scholar
  44. Liehr JG, Ricci MJ (1996) 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc Natl Acad Sci USA 93(8): 3294–3296PubMedCrossRefGoogle Scholar
  45. Linet MS, Hatch EE, Kleinerman RA et al. (1997) Residential exposure to magnetic fields and acute lymphoblastic leukemia in children. N Engl J Med 337: 44–46CrossRefGoogle Scholar
  46. Liu H, Wormke M, Safe SH, Bjeldanes LF (1994) Indolo[3,2-b]carbazole: a dietary-derived factor that exhibits both antiestrogenic and estrogenic activity. J Natl Cancer Inst 86(23): 1758–1765PubMedCrossRefGoogle Scholar
  47. Lloyd RV, Rosen PP, Sarkar NH et al. (1983) Murine mammary tumor virus related antigen in human male mammary carcinoma. Cancer 51(4): 654–61PubMedCrossRefGoogle Scholar
  48. Löscher W, Wahnschaffe U, Mevissen M, Lerchl A, Stamm A (1994) Effects of weak alternating magnetic fields on nocturnal melatonin production and mammary carcinogenesis in rats Oncology 51: 288–295Google Scholar
  49. Loomis DP, Savitz DA, Ananth CV (1994) Breast cancer mortality among female electrical workers in the United States. J Natl Cancer Inst 86(12): 921–925PubMedCrossRefGoogle Scholar
  50. López-Carillo L, Blair A, López-Cervantes M et al. (1997) Di-chlorodiphenyltrichloroethane serum levels and breast cancer risk: a case control study from Mexico. Cancer Res 57: 3728–3732Google Scholar
  51. Matanoski GM, Breysse PN, Elliott EA (1991) Electromagnetic field exposure and male breast cancer. Lancet 337:737PubMedCrossRefGoogle Scholar
  52. McIntyre IM, Norman TR, Burrows GD, Armstrong SM (1989) Human melatonin suppression by light is intensity dependent. J Pineal Res 6:149–156PubMedCrossRefGoogle Scholar
  53. Morabia A, Bernstein M, Heritier S, Khatchatrian N (1996) Relation of breast cancer with passive and active exposure to tobacco smoke. Am J Epidemiol 143(9): 918–928PubMedCrossRefGoogle Scholar
  54. Mussalo-Rauhamaa H, Häsänen E, Pyysalo H, Antervo K, Kauppila R, Pantzar P (1990) Occurrence of Beta-Hex-achlorcyclohexane in breast cancer patients. Cancer 66: 2124–2118PubMedCrossRefGoogle Scholar
  55. Nagel SC, vom Saal FS, Thayer KA, Dhar MG, Boechler M, Welshons WV (1997) Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens Bisphenol A and octylphenol. Environ. Health Perspect 105: 70–76PubMedCrossRefGoogle Scholar
  56. Nagel SC, vom Saal FS, Welshons WV (1999) Developmental effects of estrogenic chemicals are predicted by an in vitro assay incorporating modification of cell uptake by serum. J Steroid Biochem Mol Biol 69:343–357PubMedCrossRefGoogle Scholar
  57. Osborne MP, Bradlow HL, Wong GY, Telang NT (1993) Upregulation of estradiol C16 alpha-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk. J Natl Cancer Inst 85:1917–1920PubMedCrossRefGoogle Scholar
  58. Pollan M, Gustavsson P (1999) High-risk populations for breast cancer in the Swedish female working population. Am J Public Health 89: 875–881PubMedCrossRefGoogle Scholar
  59. Preston-Martin S (1996) Breast cancer and magnetic fields. Epidemiology 7: 457–458PubMedGoogle Scholar
  60. Pyykkö K, Tuimala R, Aalto L, Perkiö T (1991) Is hydrocarbon hydroxylase a new prognostic indicator for breast cancer? Br J Cancer 63: 596–600PubMedCrossRefGoogle Scholar
  61. Reichman ME, Judd JT, Longcope C et al. (1993) Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. J Natl Cancer Inst 85(9): 722–727PubMedCrossRefGoogle Scholar
  62. Reiter RJ (1985) Action spectra, dose-response relationships, and temporal aspects of light’s effects on the pineal gland. Ann NY Acad Sci 453: 215–230PubMedCrossRefGoogle Scholar
  63. Rosenbaum PF, Vena JE, Zielezny MA, Michalek AM (1994) Occupational exposure associated with male breast cancer. Am J Epidemiol 140: 974–979Google Scholar
  64. Savitz D (1994) Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women. Journal of the National Cancer Institute 86:1255–1256PubMedCrossRefGoogle Scholar
  65. Schäfer WR, Zahradnik HP, Frijus-Plessen N, Schneider K (1996) Anthropogene Substanzen mit unerwünschter Östro-genwirkung: Auswahl von expositions-relevanten Stoffen. Umweltmed Forsch Prax 1:35–42Google Scholar
  66. Segal-Eiras A, Croce MV, Pasqualini CD (1983) Antibodies presumably cross-reacting with mouse retrovirus type B and C in the sera of both leukemia-lymphoma and mammary cancer patients. Arch Geschwulstforsch 53 (4): 321–327PubMedGoogle Scholar
  67. Stevens RG (1987) Electric power use an d breast cancer: a hypothesis. Am J Epidemiol 125:556–561PubMedGoogle Scholar
  68. Stevens RG (1993) Breast cancer and electric power. Biomed Pharmacother 47 (10): 435–438PubMedCrossRefGoogle Scholar
  69. Stevens RG, Davis S (1996) The melatonin hypothesis: Electric power and breast cancer. Environ Health Perspect 104 (Sup-pl.1): 135–140PubMedGoogle Scholar
  70. Strahlenschutzkommission (1995) Schutz von niederfrequenten elektrischen und magnetischen Feldern der Energieversorgung und -anwendung. Empfehlungen der Strahlenschutzkommission vom 10.5.1995. Bundesanzeiger 47, Nr. 147 a, 8. August 1995Google Scholar
  71. Tiwari RK, Guo L, Bradlow HL, Telang NT, Osborne MP (1994). Selective responsiveness of human breast cancer cells to in-dole-3-carbinol, a chemopreventive agent. J Natl Cancer Inst 86(2): 126–131PubMedCrossRefGoogle Scholar
  72. Trichopoulos D (1994) Are electric or magnetic fields affecting mortality from breast cancer in women? Editorial. J Natl Cancer Inst 86: 885–886PubMedGoogle Scholar
  73. Tynes T (1993) Electromagnetic fields and male breast cancer. Biomed Pharmacother 47:425–427PubMedCrossRefGoogle Scholar
  74. Tynes T, Andersen A (1990) Electromagnetic field exposure and male breast cancer. Lancet 336:1596PubMedCrossRefGoogle Scholar
  75. Vagerö D, Ahlbom A, Olin R et al. (1985) Cancer morbidity among workers in the telecommunication industry. Br J Ind Med 42: 211–212PubMedGoogle Scholar
  76. Verordnung (1996) Verordnung zur Durchführung des Bundesimmissionsschutzgesetzes (Verordnung über elektromagnetische Felder). Bundesgesetzblatt I vom 16.12.1996:1966Google Scholar
  77. Wartenberg D (1996) EMFs: Cutting through the controversy. Public Health Rep 3: 204–217Google Scholar
  78. Wartenberg D (1998) Residential magnetic fileds and childhood leukemia: a meta-analysis. Am J Public Health 88:1787–1794PubMedCrossRefGoogle Scholar
  79. Wassermann M, Nogueira DP, Tomatis L et al. (1976) Organo-chlorine compounds in neoplastic and adjacent apparently normal breast tissue. Bull Environ Contam Toxicol 15: 478–484PubMedCrossRefGoogle Scholar
  80. Westin JB, Richter E (1990) The Israeli Breast-Cancer Anomaly. Ann NY Acad Sci 609: 269–279PubMedCrossRefGoogle Scholar
  81. Wichmann HE, Schlipköter HW, Fülgraff G (1992) Handbuch der Umweltmedizin. Landsberg: Ecomed-VerlagGoogle Scholar
  82. Wolff MS, Collmann GW, Barett JC, Huff J (1996) Breast cancer and environmental risk factors: epidemiological and experimental findings. Annu Rev Pharmacol Toxicol 36: 573–596PubMedCrossRefGoogle Scholar
  83. Wolff MS, Toniolo PG, Lee EW, Rivera M, Dubin N(1993) Blood levels of organo chlorine residues and risk of breast cancer. J Natl Canc Inst 85 (8): 648–652CrossRefGoogle Scholar
  84. Yager JD, Liehr JG (1996) Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 36:203–232PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • V. Hanf

There are no affiliations available

Personalised recommendations